| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |